Skip to main content
G

GRIDX

GRIDX is an Argentina-based fund and company builder that turns scientific research into early-stage biotech startups across the Latin American bioeconomy.

GRIDX is a venture fund and company builder founded in 2015 and based in Buenos Aires, Argentina. It operates at the intersection of scientific research and early-stage company formation in the bioeconomy - the range of economic activity that derives value from biological processes, spanning agriculture, human health, food, energy, materials and bioindustry. The firm's stated model pairs scientists with entrepreneurs to convert research into biotech ventures, targeting interdisciplinary founding teams and building towards startup independence and global markets.

Its principal vehicle is the TRANSFORM program, a hands-on offering that discovers science and entrepreneurial talent across Latin America, supports team formation, strategy and early resourcing, and invests in selected startups. According to the firm, the program has catalysed more than 90 biotech startups across eight Latin American countries.

Technical domains covered include synthetic biology, deep tech, life sciences, agricultural biotech, healthcare biotech, biomaterials and bioindustry. GRIDX describes its philosophy as "life-centered" and its approach as company-building rather than passive capital provision; specific fund size, stage of entry and check size are not disclosed.

Open jobs

No open jobs right now.